Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 171

1.

Local Stem Cell Therapy for Crohn's Perianal Fistulae.

Franco DL, Holubar SD, Lightner AL, Lashner BA, Shen B.

Inflamm Bowel Dis. 2018 Dec 11. doi: 10.1093/ibd/izy362. [Epub ahead of print] No abstract available.

PMID:
30535351
2.

Conflicts of Interest in Clinical Practice Guidelines.

Lashner BA, Cominelli F.

Inflamm Bowel Dis. 2019 Mar 14;25(4):646. doi: 10.1093/ibd/izy317. No abstract available.

PMID:
30295815
3.

Inflammatory Bowel Disease and Irritable Bowel Syndrome: What to Do When There Is an Overlap.

Kamal A, Padival R, Lashner B.

Inflamm Bowel Dis. 2018 Nov 29;24(12):2479-2482. doi: 10.1093/ibd/izy277. No abstract available.

PMID:
30169572
4.

Reviewing the Risk of Colorectal Cancer in Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis.

Rao BB, Lashner B, Kowdley KV.

Inflamm Bowel Dis. 2018 Jan 18;24(2):269-276. doi: 10.1093/ibd/izx056.

PMID:
29361103
5.

Changes, Changes, Changes.

Lashner B, Cominelli F, Petrylak A, Heller C.

Inflamm Bowel Dis. 2017 Dec 19;24(1):1. doi: 10.1093/ibd/izx074. No abstract available.

PMID:
29272496
6.

Corrigendum to "Low Body Mass Index Can Identify Majority of Osteoporotic Inflammatory Bowel Disease Patients Missed by Current Guidelines".

Atreja A, Aggarwal A, Licata AA, Lashner BA.

ScientificWorldJournal. 2017;2017:3937676. doi: 10.1155/2017/3937676. Epub 2017 Aug 14.

7.

Efficacy, Safety, and Long-term Outcome of Serial Endoscopic Balloon Dilation for Upper Gastrointestinal Crohn's Disease-associated Strictures-A Cohort Study.

Singh A, Agrawal N, Kurada S, Lopez R, Kessler H, Philpott J, Shen B, Lashner B, Rieder F.

J Crohns Colitis. 2017 Sep 1;11(9):1044-1051. doi: 10.1093/ecco-jcc/jjx078.

8.

Utility of Biomarkers in the Management of Inflammatory Bowel Disease.

Kochhar G, Lashner B.

Curr Treat Options Gastroenterol. 2017 Mar;15(1):105-115. doi: 10.1007/s11938-017-0129-z. Review.

PMID:
28138859
9.

Our Vision for the Future of Inflammatory Bowel Diseases: Research, Innovations, and Controversies.

Lashner B, Cominelli F.

Inflamm Bowel Dis. 2017 Jan;23(1):1. doi: 10.1097/MIB.0000000000001018. No abstract available.

PMID:
28002124
10.

Antiviral Treatment for Colonic Cytomegalovirus Infection in Ulcerative Colitis Patients Significantly Improved Their Surgery Free Survival.

Wang Y, Aggarwal P, Liu X, Lu H, Lian L, Wu X, Guo S, Aggarwal N, Lashner B, Shen B.

J Clin Gastroenterol. 2018 Apr;52(4):e27-e31. doi: 10.1097/MCG.0000000000000759.

PMID:
27875354
11.

Impact of Low Immunoglobulin G Levels on Disease Outcomes in Patients with Inflammatory Bowel Diseases.

Horton N, Wu X, Philpott J, Garber A, Achkar JP, Brzezinski A, Lashner BA, Shen B.

Dig Dis Sci. 2016 Nov;61(11):3270-3277. Epub 2016 Sep 12.

PMID:
27619393
12.

Implementation of Clinical Pharmacogenomics within a Large Health System: From Electronic Health Record Decision Support to Consultation Services.

Hicks JK, Stowe D, Willner MA, Wai M, Daly T, Gordon SM, Lashner BA, Parikh S, White R, Teng K, Moss T, Erwin A, Chalmers J, Eng C, Knoer S.

Pharmacotherapy. 2016 Aug;36(8):940-8. doi: 10.1002/phar.1786. Epub 2016 Jul 20.

PMID:
27312955
13.

Autoimmune features are associated with chronic antibiotic-refractory pouchitis.

Seril DN, Yao Q, Lashner BA, Shen B.

Inflamm Bowel Dis. 2015 Jan;21(1):110-20. doi: 10.1097/MIB.0000000000000231.

PMID:
25437817
14.

Safety and efficacy of endoscopic dilation for primary and anastomotic Crohn's disease strictures.

Atreja A, Aggarwal A, Dwivedi S, Rieder F, Lopez R, Lashner BA, Brzezinski A, Vargo JJ, Shen B.

J Crohns Colitis. 2014 May;8(5):392-400. doi: 10.1016/j.crohns.2013.10.001. Epub 2013 Nov 1.

PMID:
24189349
15.

Hospital readmissions in patients with inflammatory bowel disease.

Hazratjee N, Agito M, Lopez R, Lashner B, Rizk MK.

Am J Gastroenterol. 2013 Jul;108(7):1024-32. doi: 10.1038/ajg.2012.343.

PMID:
23820989
16.

Similar outcomes of IBD inpatients with Clostridium difficile infection detected by ELISA or PCR assay.

Wang Y, Atreja A, Wu X, Lashner BA, Brzezinski A, Shen B.

Dig Dis Sci. 2013 Aug;58(8):2308-13. doi: 10.1007/s10620-013-2641-x. Epub 2013 Mar 24.

PMID:
23525735
17.

Avoiding narcotics in Crohn's disease.

Jackson WE, Rizk M, Lashner BA.

J Clin Gastroenterol. 2013 Apr;47(4):293-5. doi: 10.1097/MCG.0b013e318278aeec. No abstract available.

PMID:
23426445
18.

Manometric evaluation of evacuatory difficulty (dyschezia) in ileal pouch patients.

Khanna R, Li Y, Schroeder T, Brzezinski A, Lashner BA, Kiran RP, Remzi RH, Shen B.

Inflamm Bowel Dis. 2013 Mar;19(3):569-75. doi: 10.1097/MIB.0b013e31827e78d6.

PMID:
23380934
19.

Effects of immunosuppression and liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis.

Navaneethan U, Lashner BA.

Clin Gastroenterol Hepatol. 2013 May;11(5):524-5. doi: 10.1016/j.cgh.2013.01.020. Epub 2013 Jan 30. No abstract available.

PMID:
23376317
20.

Quality commitment: the newly established American College of Gastroenterology Quality Council to meet the needs of clinical gastroenterology.

Kane S, Leighton J, Kefalas C, Cohen L, Katz P, Rizk M, Pike I, Lashner B, Ho I, Pochapin M, Seabrook M, Greenwald D, Demarco D, Johnson D.

Am J Gastroenterol. 2013 Jan;108(1):7-9. doi: 10.1038/ajg.2012.319. No abstract available.

PMID:
23287937

Supplemental Content

Loading ...
Support Center